These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 2086561

  • 41. Rabbit pulmonary cytochrome P-450 monooxygenase system: isozyme differences in the rate and stereoselectivity of styrene oxidation.
    Harris C, Philpot RM, Hernandez O, Bend JR.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):144-9. PubMed ID: 3941390
    [Abstract] [Full Text] [Related]

  • 42. NADPH and oxygen consumption in isoflurane-facilitated 2-chloro-1,1- difluoroethene metabolism in rabbit liver microsomes.
    Wang Y, Baker MT.
    Drug Metab Dispos; 1993 Jan; 21(2):299-304. PubMed ID: 8097700
    [Abstract] [Full Text] [Related]

  • 43. Role of P450IIE1 in the metabolism of 3-hydroxypyridine, a constituent of tobacco smoke: redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridine.
    Kim SG, Novak RF.
    Cancer Res; 1990 Sep 01; 50(17):5333-9. PubMed ID: 2167153
    [Abstract] [Full Text] [Related]

  • 44. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T, Imaoka S, Hiroi T, Funae Y.
    Res Commun Mol Pathol Pharmacol; 1996 Sep 01; 93(3):363-74. PubMed ID: 8896047
    [Abstract] [Full Text] [Related]

  • 45. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
    Foureman GL, Harris C, Guengerich FP, Bend JR.
    J Pharmacol Exp Ther; 1989 Feb 01; 248(2):492-7. PubMed ID: 2918465
    [Abstract] [Full Text] [Related]

  • 46. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
    Huwyler J, Aeschlimann D, Christen U, Gut J.
    Eur J Biochem; 1992 Jul 01; 207(1):229-38. PubMed ID: 1628651
    [Abstract] [Full Text] [Related]

  • 47. Interaction of fluoroethane chlorofluorocarbon (CFC) substitutes with microsomal cytochrome P450. Stimulation of P450 activity and chlorodifluoroethene metabolism.
    Wang Y, Olson MJ, Baker MT.
    Biochem Pharmacol; 1993 Jul 06; 46(1):87-94. PubMed ID: 8347140
    [Abstract] [Full Text] [Related]

  • 48. Extrahepatic tissue distribution, covalent binding, and toxicity of halothane in control and phenobarbital-pretreated rats.
    Rao GS, Grumley JO.
    Pharmacol Ther Dent; 1978 Jul 06; 3(2-4):101-9. PubMed ID: 286368
    [Abstract] [Full Text] [Related]

  • 49. A spin trap study on anaerobic dehalogenation of halothane by a reconstituted liver microsomal cytochrome P-450 enzyme system.
    Fujii K, Miki N, Kanashiro M, Miura R, Sugiyama T, Morio M, Yamano T, Miyake Y.
    J Biochem; 1982 Jan 06; 91(1):415-8. PubMed ID: 6279588
    [Abstract] [Full Text] [Related]

  • 50. Inhibitory effect of gomisi on reductive metabolism of halothane.
    Jiaxiang N, Fujii K, Sato N, Yuge O.
    J Appl Toxicol; 1993 Jan 06; 13(6):385-8. PubMed ID: 8288841
    [Abstract] [Full Text] [Related]

  • 51. Enzyme inhibition by analgesic and hypnotic agents on anaerobic dehalogenation of halothane.
    Yamanoue T, Kikuchi H, Fujii K, Yuge O, Kawahara M, Morio M.
    J Anesth; 1991 Oct 06; 5(4):331-7. PubMed ID: 15278600
    [Abstract] [Full Text] [Related]

  • 52. Oxisuran reduction by rabbit tissue preparations.
    Bachur NR, Felsted RL.
    Drug Metab Dispos; 1976 Oct 06; 4(3):239-43. PubMed ID: 6228
    [Abstract] [Full Text] [Related]

  • 53. Bioactivation and covalent binding of halothane to liver macromolecules.
    Sipes IG, Podolsky TL, Brown BR.
    Environ Health Perspect; 1977 Dec 06; 21():171-8. PubMed ID: 612442
    [Abstract] [Full Text] [Related]

  • 54. Mechanism of the microsomal reduction of carbon tetrachloride and halothane.
    Kubic VL, Anders MW.
    Chem Biol Interact; 1981 Mar 01; 34(2):201-7. PubMed ID: 7460083
    [Abstract] [Full Text] [Related]

  • 55. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
    Gourlay GK, Adams JF, Cousins MJ, Sharp JH.
    Br J Anaesth; 1980 Mar 01; 52(3):331-6. PubMed ID: 7370149
    [Abstract] [Full Text] [Related]

  • 56. Disposition of 14C-mescaline by rabbit lung.
    Roth RA, Roth JA, Gillis CN.
    J Pharmacol Exp Ther; 1977 Feb 01; 200(2):394-401. PubMed ID: 839444
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Metabolic activation of halothane to neoantigens in C57Bl/10 mice: immunochemical studies.
    Heijink E, De Matteis F, Gibbs AH, Davies A, White IN.
    Eur J Pharmacol; 1993 Jun 01; 248(1):15-25. PubMed ID: 8339751
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.